Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GSK
GSK
GSK still has a crush on oligonucleotides, sealing the deal with Elsie
Fierce Biotech
Wed, 02/14/24 - 10:53 am
GSK
oligonucleotides
Elsie Biotechnologies
FDA fast-tracks GSK’s chronic hep B therapy bepirovirsen
Pharmaphorum
Mon, 02/12/24 - 10:28 am
GSK
FDA
fast track
hepatitis B
bepirovirsen
antisense
GSK reports positive news on trio of high-profile products
Medical Marketing and Media
Wed, 02/7/24 - 09:13 pm
GSK
Arexvy
RSV
Abrysvo
Blenrep
GSK’s Blenrep Combo Scores Phase III Win in Multiple Myeloma
BioSpace
Tue, 02/6/24 - 09:25 am
GSK
Blenrep
Multiple Myeloma
clinical trials
GSK’s Arexvy Leads Over Pfizer’s Abrysvo in Year One of RSV Vaccine Market Battle
Xtalks
Mon, 02/5/24 - 11:12 pm
GSK
Pfizer
RSV
Arexvy
Abrysvo
vaccines
GSK sees strong growth as Haleon split and vaccine drive pays off
Reuters
Wed, 01/31/24 - 11:53 am
GSK
earnings
Haleon
vaccines
GSK confirms Arexvy is a blockbuster but says the RSV battle has just begun
Fierce Pharma
Wed, 01/31/24 - 11:49 am
GSK
Pfizer
RSV
vaccines
Arexvy
GSK RSV vaccine achieves blockbuster status in just over six months
Tip Ranks
Mon, 01/29/24 - 10:30 pm
GSK
RSV
vaccines
Arexvy
Pfizer
After GSK and Novartis handoffs, Laekna's drug fails ovarian cancer trial
Fierce Biotech
Mon, 01/29/24 - 10:27 pm
Laekna
afuresertib
clinical trials
ovarian cancer
GSK
Novartis
Incyte vets, with phase 1 within reach, raise $102M for new biotech to create better PARP, PI3K drugs
Fierce Biotech
Wed, 01/24/24 - 10:35 am
Synnovation Therapeutics
Incyte
AstraZeneca
GSK
Novartis
Pfizer
funding
cancer
PARP inhibitors
Next stage in GSK’s Zantac defense gets underway today
Pharmaphorum
Mon, 01/22/24 - 11:13 am
GSK
Zantac
legal
cancer
GSK raises $1.24 bln from latest Haleon stake sale
Reuters
Wed, 01/17/24 - 09:22 am
GSK
consumer health
Haleon
spinoffs
GSK Puts $1.4B on the Line in Aiolos Acquisition to Boost Asthma Pipeline
BioSpace
Tue, 01/9/24 - 09:50 am
GSK
Aiolos Bio
M&A
asthma
JPMHC 2024
Curevo’s shingles vaccine equals GSK’s Shingrix in phase 2 head-to-head
Fierce Biotech
Tue, 01/9/24 - 09:47 am
Curevo Vaccine
GSK
shingles
vaccines
Shingrix
GSK amends commercial deal with Scynexis as antifungal recall drags into 2024
Fierce Pharma
Wed, 01/3/24 - 04:57 pm
GSK
Scynexis
Brexafemme
antifungals
GSK heads back to Hansoh, paying $185M upfront for another ADC
Fierce Biotech
Wed, 12/20/23 - 09:46 am
GSK
Hansoh Pharmaceutical
antibody-drug conjugate
GSK's cancer drug combination meets primary goal in late-stage trial
Reuters
Mon, 12/18/23 - 10:10 am
GSK
Zejula
Jemperli
endometrial cancer
clinical trials
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster Status
BioSpace
Fri, 12/1/23 - 11:30 am
GSK
Pfizer
RSV
vaccines
Arexvy
GSK CEO says RSV vaccine revenue to top 1 bln pounds in first year
Reuters
Thu, 11/30/23 - 11:12 pm
GSK
RSV
vaccines
Emma Walmsley
Pharma CEOs
After watching Merck's chronic cough drama, GSK knew exactly what not to do with Bellus asset
Fierce Biotech
Thu, 11/30/23 - 10:07 am
Merck
GSK
chronic cough
Bellus Health
gefapixant
Camlipixant
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »